Allient Inc. (ALNT)
NASDAQ:ALNT
Want to see ALNT full AI Analyst Report?
Top Page
Allient
(NASDAQ:ALNT)
Select Model
Select Model
Rating:67Neutral
Price Target:
$104.00
▲(39.78% Upside)
Action:Reiterated
Date:06/01/26
ALNT scores as a balanced setup: improving profitability/leverage and a constructive earnings update with strong orders/backlog support the outlook, while technicals are bullish but nearing overbought. The primary constraint is valuation, with a high P/E and minimal dividend yield, plus some near-term cost and cash-flow pressures flagged on the call.
Positive Factors
Gross-margin expansion and improved profitability
Sustained gross margins near 32–33% driven by better mix and operational improvements indicate durable operating leverage. Higher-margin product mix and STAN program gains reduce sensitivity to volume swings, supporting midterm margin sustainability as the company scales productized offerings.
Negative Factors
Weak organic revenue growth
Modest organic growth implies underlying demand and market penetration remain tepid absent FX effects. Over the medium term, slow organic expansion increases dependence on product transitions, M&A or pricing to drive revenue, creating execution risk if new scalable products or channels underperform.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross-margin expansion and improved profitability
Sustained gross margins near 32–33% driven by better mix and operational improvements indicate durable operating leverage. Higher-margin product mix and STAN program gains reduce sensitivity to volume swings, supporting midterm margin sustainability as the company scales productized offerings.
Read all positive factors
Allient (ALNT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.63B
Dividend Yield0.22%
Average Volume (3M)286.54K
Price to Earnings (P/E)67.2
Beta (1Y)1.50
Revenue Growth8.63%
EPS Growth141.02%
CountryUS
Employees2,525
SectorTechnology
Sector Strength88
IndustryHardware, Equipment & Parts
Share Statistics
EPS (TTM)1.43
Shares Outstanding16,996,511
10 Day Avg. Volume275,698
30 Day Avg. Volume286,539
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.97
Price to Sales (P/S)1.62
P/FCF Ratio18.03
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue3.12
Enterprise Value/Gross Profit10.00
Enterprise Value/Ebitda22.11
Forecast
1Y Price Target
$73.80Price Target Upside-0.81% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.53
Revenue Forecast (FY)$584.11M
Allient Business Overview & Revenue Model
Company Description
Allient Inc., headquartered in Amherst, New York, and founded in 1962, is a global enterprise specializing in the engineering, production, and distribution of high-precision, specialized controlled motion components and integrated systems. The com...
How the Company Makes Money
Allient primarily makes money by selling engineered motion-control and power-management products and systems to OEMs and industrial customers. Revenue is generated from (1) product sales of motion solutions—such as motors, drives/controls, and enc...
Allient Earnings Call Summary
Earnings Call Date:May 06, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 05, 2026
Earnings Call Sentiment Positive
Overall the call conveys a constructive and improving business profile: revenue, bookings, backlog, gross margin and earnings showed year-over-year improvement, balance sheet leverage declined, and management is investing in higher-value products and accelerating go-to-market initiatives. However, near-term headwinds—Dothan transition costs, elevated SG&A and IT spending, a modest organic revenue increase on a constant currency basis, adjusted EBITDA being slightly below prior period, cash flow timing effects, and trade-policy uncertainty—temper the near-term outlook. Management expects many of the transition-related costs to abate and margin benefits to materialize in the second half of the year, and they increased the dividend as a sign of confidence.Positive Updates
Revenue Growth
Total revenue increased 5% year-over-year to $138.9 million; on a constant currency basis organic revenue grew 1%, with $5.1 million of favorable foreign currency translation.
Negative Updates
Weak Organic Growth on Constant Currency
Organic revenue growth on a constant currency basis was only 1% for the quarter, indicating underlying demand momentum is still modest absent FX tailwinds.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth
Total revenue increased 5% year-over-year to $138.9 million; on a constant currency basis organic revenue grew 1%, with $5.1 million of favorable foreign currency translation.
Read all positive updates
Company Guidance
Management gave limited formal guidance but provided several quantitative forward-looking items and context: they expect full‑year 2026 restructuring and realignment costs of approximately $2–3 million, full‑year capital expenditures of roughly $12–15 million (Q1 CapEx was $2.2M), and a full‑year effective tax rate of 21–23%; they expect the Dothan transition to be completed/stabilized with most benefits realized in H2 (targeting substantial cost elimination by end‑Q3). They also pointed to operating momentum underpinning the outlook — Q1 orders of $158.1M (+15% YoY, +9% sequential) produced a book‑to‑bill of 1.14x and backlog of $251M (majority converting in ~3–5/3–6 months) — while Q1 results provided the baseline (revenue $138.9M, +5% YoY / +1% organic CC; gross profit $45.4M, gross margin 32.7% +50 bps YoY; operating income $9.3M or 6.7%; adjusted EBITDA $17.3M or 12.4%; adjusted net income $8.4M, $0.50/sh; net income $5.4M, $0.32/sh). Financial flexibility cited included $41.2M cash, $177.3M total debt (net debt $136.1M), net‑debt/ttm adjusted EBITDA 1.78x, bank leverage 2.24x, and $158M of unused revolver capacity.Allient Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
69
Positive
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 560.59M | 554.48M | 529.97M | 578.63M | 502.99M | 403.52M |
| Gross Profit | 174.96M | 169.24M | 165.69M | 183.68M | 157.26M | 121.06M |
| EBITDA | 79.10M | 81.94M | 56.05M | 67.15M | 56.86M | 44.46M |
| Net Income | 23.83M | 22.03M | 13.17M | 24.10M | 17.39M | 24.09M |
Balance Sheet | ||||||
| Total Assets | 577.66M | 577.60M | 575.78M | 597.54M | 588.35M | 470.79M |
| Cash, Cash Equivalents and Short-Term Investments | 41.17M | 40.70M | 36.10M | 31.90M | 30.61M | 22.46M |
| Total Debt | 198.07M | 202.63M | 249.13M | 243.49M | 258.85M | 176.28M |
| Total Liabilities | 271.74M | 276.14M | 310.93M | 345.97M | 372.88M | 283.02M |
| Stockholders Equity | 305.93M | 301.45M | 264.85M | 251.57M | 215.47M | 187.76M |
Cash Flow | ||||||
| Free Cash Flow | 40.82M | 49.69M | 32.17M | 33.44M | -10.31M | 11.69M |
| Operating Cash Flow | 48.92M | 56.67M | 41.85M | 45.04M | 5.60M | 25.40M |
| Investing Cash Flow | -8.10M | -6.99M | -34.91M | -22.61M | -60.01M | -60.97M |
| Financing Cash Flow | -48.64M | -47.70M | -843.00K | -21.32M | 63.60M | 35.83M |
Allient Technical Analysis
Positive
74.40
Price Trends
75.61
Positive
69.61
Positive
60.87
Positive
Market Momentum
6.54
Negative
71.88
Negative
74.98
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ALNT, the sentiment is Positive. The current price of 74.4 is below the 20-day moving average (MA) of 83.98, below the 50-day MA of 75.61, and above the 200-day MA of 60.87, indicating a bullish trend. The MACD of 6.54 indicates Negative momentum. The RSI at 71.88 is Negative, neither overbought nor oversold. The STOCH value of 74.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ALNT.
Allient Risk Analysis
Allient disclosed 32 risk factors in its most recent earnings report. Allient reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Allient Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $976.55M | 35.13 | 8.90% | 1.07% | 11.42% | 5.37% | |
67 Neutral | $1.63B | 67.22 | 8.01% | 0.22% | 8.63% | 141.02% | |
66 Neutral | $1.00B | 36.71 | 9.64% | ― | 0.36% | 1138.56% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $1.88B | 317.68 | 1.77% | ― | 7.51% | 93.82% | |
55 Neutral | $901.80M | 482.21 | 4.31% | ― | -22.63% | ― | |
51 Neutral | $1.08B | -12.03 | -98.63% | ― | -8.93% | 1.81% |
* Technology Sector Average
ALNT
Allient
95.85
62.21
184.95%
DAKT
Daktronics
20.76
6.53
45.89%
KOPN
Kopin
4.93
3.30
202.45%
LYTS
Lsi Industries
26.60
10.58
66.04%
VPG
Vishay Precision Group
141.34
115.41
445.08%
BKSY
BlackSky Technology
28.99
14.77
103.87%
Allient Corporate Events
Executive/Board ChangesShareholder Meetings
Allient Shareholders Reaffirm Board, Pay, and Auditor
Positive
May 11, 2026
Allient Inc. held its annual stockholders’ meeting on May 6, 2026, where investors elected six director nominees to the company’s board based on votes cast from 17,018,097 outstanding common shares as of the March 11, 2026 record date....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.